1[1]Kinsella JP, Abman SH. Recent developments in the pathophysiology and tretment of persistent pulmonary hypertension of newborn. J Pediatr, 1995,126:853-864.
2[3]Engle EA,Yoder MC, Andreoli SP,et al.Controlled prospective randomized comparison of high-frequency jet ventilation and conventional wvetilation in neonates with respiatory failure and persistent pulmonary hypertension. J Perinatol 1997,17:3-9
3[4]Kinsella JP,Truog WE,Walsh WF, et al. Randomized multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997,131:55-62.
4[5]Thebaud B, Mercier JC. Inhaled nitric oxide: a physiologic treatment of persistent pulmonary arterial hypertension in the newborn. Arch-Pediatr, 1997,4:988-1003.
5[7]Colonna F, Giorgi, R, Ciana G,et al. Efficacy of magnesium in a case of neonatal pulmonary hypertension refractouy to the usual therapies. Minerva, Pediatr, 1994,46:553-5.
6[8]Soditt V, Aring C, Groneck P, et al. Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn. Intensive Care Med, 1997,23:1275-8.
7[9]Welch JC,Bridson JM,Gibbs JL,et al. Endotracheal tolazoline for severe persistent pulmonary hypertension of the newborn. Br Heart J. 1995,73:99-100.
3Ghofrani HA, Pepke-Zaba J, Barbera JA, et al. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol,2004,43( 12 Suppl S) :68S-72S.
4Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med,2004,351 (14) :1425-1436.
5Leuchte HH, Schwaiblmair M, Baumgartner RA, et al. Hemodynamic response to sildenafil, nitricoxide, and iloprost in primary pulmonary hypertension. Chest, 2004,125 ( 2 ) : 580 -586.
6Mikhail GW, Prasad SK, Li W, et al. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension:acute and midterm effects. Eur Heart J,2004,25 ( 5 ) : 431-436.
7Michelakis ED, Tymchak W, Noga M, et al, Long-term treatment with oral silednafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation, 2003,108 ( 17 ) : 2066-2069.
8Van Matter LJ. Persistant pulmonary hypertension of the newborn. In:Clduety JP, Stark AK, eds . Manual of neonatal care. 4th ed. Philodelphia: Lippincott Raven, 1998.364,369.
9Skimming JW, Demarco VG, Cassin S. The effects of nitric oxide inhalation on the pulmonarg circulation of preterm lambs. Pediatr Res, 1995,37:35.
